首页 › 基金 › Israel Discount Bank of New York › BIIB

Israel Discount Bank of New York 对 BIIB 的持仓历史

BIOGEN INC · 医疗保健

Israel Discount Bank of New York 在 Q3 2026 的 13F 申报中披露持有 BIIB(BIOGEN INC)1,055 股,市值约 US$238K,约占其申报组合的 0.43%,在其申报持仓中市值排名第 42 位。 Israel Discount Bank of New York 最近 13 个申报季度中有 9 个季度披露了 BIIB 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)1.05K 股
申报持仓市值$238.30K
组合权重0.43%
首次申报Q3 2023
最近变动持有
更新于2026-10-14

最后更新: 2026-10-14 · 来源: SEC EDGAR Form 13F-HR

Israel Discount Bank of New York 对 BIIB 的持仓演变

Israel Discount Bank of New York 于 Q3 2023 首次披露 BIIB 持仓:2,210 股(约 US$568K)。 在 9 次申报中,Israel Discount Bank of New York 2 次增持、3 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 1,055 股、市值约 US$238K。

逐季持仓明细

季度股数金额变化
Q3 2023 2.21K $567.99K 新进
Q4 2023 2.13K $550.14K 减持
Q1 2024 1.62K $349.97K 减持
Q2 2024 1.24K $287.69K 减持
Q3 2024 1.32K $256.45K 增持
Q4 2024 1.41K $214.85K 增持
Q3 2025 1.45K $203.54K 新进
Q2 2026 1.05K $227.94K 新进
Q3 2026 1.05K $238.30K 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 BIIB 与 13F 数据

BIIB(BIOGEN INC)属于医疗保健行业。我们追踪的基金中还有 22 只申报持有 BIIB,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$3.27B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BIIB 的基金

查看 BIIB 的全部基金持有人 →

常见问题

How long has Israel Discount Bank of New York held BIIB?

Israel Discount Bank of New York has disclosed BIIB holdings in 9 of the last 13 reported quarters, going back to Q3 2023.

What is Israel Discount Bank of New York's current position in BIIB?

As of Q3 2026, Israel Discount Bank of New York holds 1.05K shares of BIIB (BIOGEN INC), valued at $238.30K, representing 0.43% of its reported portfolio and ranking #42.

Has Israel Discount Bank of New York been buying or selling BIIB?

In the latest 13F filing (Q3 2026), Israel Discount Bank of New York held unchanged its position in BIIB.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.